GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » YoY Rev. per Sh. Growth

Control Bionics (ASX:CBL) YoY Rev. per Sh. Growth : -55.56% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Control Bionics's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 was -55.56%.

Control Bionics's Revenue per Share for the six months ended in Dec. 2024 was A$0.01.

Control Bionics YoY Rev. per Sh. Growth Historical Data

The historical data trend for Control Bionics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics YoY Rev. per Sh. Growth Chart

Control Bionics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
YoY Rev. per Sh. Growth
- -19.30 17.39 -40.74

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only 8.00 28.57 - -59.26 -55.56

Control Bionics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Control Bionics's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2024 )
=(Revenue per Share (A: Jun. 2024 )-Revenue per Share (A: Jun. 2023 ))/ | Revenue per Share (A: Jun. 2023 ) |
=(0.032-0.054)/ | 0.054 |
=-40.74 %

Control Bionics's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2024 )
=(Revenue per Share (Q: Dec. 2024 )-Revenue per Share (Q: Dec. 2023 )) / | Revenue per Share (Q: Dec. 2023 )) |
=(0.012-0.027)/ | 0.027 |
=-55.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Control Bionics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
ASX:HMD ASX:AT1 ASX:IRX ASX:ADRDA ASX:UCM ASX:UBI ASX:OSL ASX:CDX ASX:LDX ASX:NTI ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Website
https://www.controlbionics.com
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.